Peter Boström

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy (2016)

Bladder Cancer

Boström PJ, Thoms J, Sykes J, Ahmed O, Evans A, van Rhijn BW, Mirtti T, Stakhovskyi O, Laato M, Margel D, Pintilie M, Kuk C, Milosevic M, Zlotta AR, Bristow RG

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies (2016)

PLoS ONE

Alinezhad S, Väänänen RM, Mattsson J, Li YF, Tallgren T, Ochoa NT, Bjartell A, Åkerfelt M, Taimen P, Boström PJ, Pettersson K, Nees M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Update on novel imaging techniques for the detection of lymph node metastases in bladder cancer (2016)

Minerva Urologica e Nefrologica

Antti P. Salminen, Ivan Jambor, Kari T. Syvänen, Peter J. Boström

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Establishment of a realistic patient derived xenograft (PDX) model for prostate cancer bone metastasis (2016)

Cancer Research

Konkol Y, Valta M, Bernoulli J, Taimen P, Bostrom P, Harkonen P, Halleen J, Tuomela JM

(O2 Muu julkaisu )

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy (2016)

Scientific Reports

Laajala TD, Seikkula H, Sadat FS, Mirtti T, Boström PJ, Elo LL.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Relaxation along fictitious field, diffusion-weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness (2016)

Magnetic Resonance in Medicine

Jambor I, Pesola M, Merisaari H, Taimen P, Boström PJ, Liimatainen T, Aronen HJ

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Initiation of robot-assisted radical prostatectomies in Finland: Impact on centralization and quality of care (2016)

Scandinavian Journal of Urology

Riikonen J, Kaipia A, Petas A, Horte A, Koskimaki J, Kahkonen E, Bostrom PJ, Paananen I, Kuisma J, Santti H, Matikainen M, Rannikko A

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy (2016)

Journal of Urology

Duivenvoorden WC, Daneshmand S, Canter D, Lotan Y, Black PC, Abdi H, van Rhijn BW, Fransen van de Putte EE, Zareba P, Koskinen I, Kassouf W, Traboulsi SL, Kukreja JE, Boström PJ, Shayegan B, Pinthus JH.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Erectile dysfunction cannot be used in primary screening of pre-diabetes (2015)

Diabetes Research and Clinical Practice

Ettala OO, Korhonen PE, Syvanen KT, Kaipia AJ, Vahlberg TJ, Aarnio PT, Bostrom PJ

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly Bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: Prospective randomised finnbladder-4 study (2015)

European Urology

Järvinen R., Marttila T., Kaasinen E., Rintala E., Aaltomaa S., Kallio J., Liukkonen T., Puolakka V., Seppänen M., Tuhkanen K., Vaarala M., Viitanen J., Boström P.; FinnBladder Group

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Publications

Sort by:

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy (2016)

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies (2016)

Update on novel imaging techniques for the detection of lymph node metastases in bladder cancer (2016)

Establishment of a realistic patient derived xenograft (PDX) model for prostate cancer bone metastasis (2016)

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy (2016)

Relaxation along fictitious field, diffusion-weighted imaging, and T2 mapping of prostate cancer: Prediction of cancer aggressiveness (2016)

Initiation of robot-assisted radical prostatectomies in Finland: Impact on centralization and quality of care (2016)

Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy (2016)

Erectile dysfunction cannot be used in primary screening of pre-diabetes (2015)